ACE inhibition in cardiovascular disease

被引:63
作者
Francis, GS [1 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
10.1056/NEJM200001203420309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:201 / 202
页数:2
相关论文
共 14 条
  • [1] RAMIPRIL - REVIEW OF PHARMACOLOGY
    BECKER, RHA
    SCHOLKENS, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (10) : D3 - D11
  • [2] ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE
    BRUNNER, HR
    BUHLER, FR
    BARD, RH
    BAER, L
    GOODWIN, FT
    NEWTON, MA
    KRAKOFF, LR
    LARAGH, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) : 441 - +
  • [3] ROLE OF RENIN-ANGIOTENSIN SYSTEM IN SYSTEMIC VASOCONSTRICTION OF CHRONIC CONGESTIVE HEART-FAILURE
    CURTISS, C
    COHN, JN
    VROBEL, T
    FRANCIOSA, JA
    [J]. CIRCULATION, 1978, 58 (05) : 763 - 770
  • [4] TISSUE ANGIOTENSIN SYSTEM IN CARDIOVASCULAR MEDICINE - A PARADIGM SHIFT
    DZAU, VJ
    RE, R
    [J]. CIRCULATION, 1994, 89 (01) : 493 - 498
  • [5] GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450
  • [6] GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462
  • [7] How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen, RJ
    Lee, AFC
    Morton, JJ
    Pringle, SD
    Struthers, AD
    [J]. HEART, 1999, 82 (01) : 57 - 61
  • [8] DESIGN OF SPECIFIC INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - NEW CLASS OF ORALLY ACTIVE ANTIHYPERTENSIVE AGENTS
    ONDETTI, MA
    CUSHMAN, DW
    [J]. SCIENCE, 1977, 196 (4288) : 441 - 444
  • [9] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    Pitt, B
    Zannad, F
    Remme, WJ
    Cody, R
    Castaigne, A
    Perez, A
    Palensky, J
    Wittes, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
  • [10] Raizada M.K., 1993, CELLULAR MOL BIOL RE